Danaher set to buy purification consumables firm Phenomenex
Danaher Corporation will further extend its presence in the life sciences space through the acquisition of separations and purification firm Phenomenex.
Archives for October 11, 2016
Online API platform could help secure supply chain, says consultancy firm
Finding and validating an ingredient supplier can take up to 26 weeks says consultancy firm Rephine, which hopes to address the burden through an online API sourcing platform.
Three European and one Chinese drugmakers slammed by US FDA
The US FDA has issued fours warnings against foreign drugmakers, citing reasons including problems with QC, a non-registered facility, and finished products that “did not contain any of the labeled active ingredient.”
Is industry consolidation stifling pharma innovation?
In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.
Biotrial: transparency key as CRO moves forward in US
Biotrial looks to run 50 clinical trials per year at its new US-based facility as it says group activities are up – with the exception of Ph I activities in France.
Thermo Fisher clinical services facility in South Korea to support global trials
South Korea is leading emerging nations in clinical trial research in Asia, with the second highest number of approval clinical trial sites globally, according to Thermo Fisher.